# Prevalence of Cutaneous Enterococci at Femoral Insertion Site in Transcatheter Aortic Valve Implantation (TAVI)

> **NCT04909424** · — · COMPLETED · sponsor: **Clinique Pasteur** · enrollment: 100 (actual)

## Conditions studied

- Aortic Valve Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04909424
- **Lead sponsor:** Clinique Pasteur
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-17
- **Primary completion:** 2022-02-21
- **Final completion:** 2023-11-23
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04909424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04909424, "Prevalence of Cutaneous Enterococci at Femoral Insertion Site in Transcatheter Aortic Valve Implantation (TAVI)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04909424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*